Clinical Characteristics and Management of Patients with a Suspected COVID-19 Infection in Emergency Departments: A European Retrospective Multicenter Study.

COVID-19 dyspnea emergencies severe acute respiratory syndrome coronavirus 2 (SARSCoV-2)

Journal

Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269

Informations de publication

Date de publication:
19 Dec 2022
Historique:
received: 29 09 2022
revised: 21 11 2022
accepted: 09 12 2022
entrez: 23 12 2022
pubmed: 24 12 2022
medline: 24 12 2022
Statut: epublish

Résumé

Background: Our aim is to describe and compare the profile and outcome of patients attending the ED with a confirmed COVID-19 infection with patients with a suspected COVID-19 infection. Methods: We conducted a multicentric retrospective study including adults who were seen in 21 European emergency departments (ED) with suspected COVID-19 between 9 March and 8 April 2020. Patients with either a clinical suspicion of COVID-19 or confirmed COVID-19, detected using either a RT-PCR or a chest CT scan, formed the C+ group. Patients with non-confirmed COVID-19 (C− group) were defined as patients with a clinical presentation in the ED suggestive of COVID-19, but if tests were performed, they showed a negative RT-PCR and/or a negative chest CT scan. Results: A total of 7432 patients were included in the analysis: 1764 (23.7%) in the C+ group and 5668 (76.3%) in the C− group. The population was older (63.8 y.o. ±17.5 vs. 51.8 y.o. +/− 21.1, p < 0.01), with more males (54.6% vs. 46.1%, p < 0.01) in the C+ group. Patients in the C+ group had more chronic diseases. Half of the patients (n = 998, 56.6%) in the C+ group needed oxygen, compared to only 15% in the C− group (n = 877). Two-thirds of patients from the C+ group were hospitalized in ward (n = 1128, 63.9%), whereas two-thirds of patients in the C− group were discharged after their ED visit (n = 3883, 68.5%). Conclusion: Our study was the first in Europe to examine the emergency department’s perspective on the management of patients with a suspected COVID-19 infection. We showed an overall more critical clinical situation group of patients with a confirmed COVID-19 infection.

Identifiants

pubmed: 36556305
pii: jpm12122085
doi: 10.3390/jpm12122085
pmc: PMC9787691
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

N Engl J Med. 2020 Mar 26;382(13):1194-1196
pubmed: 32074416
J Belg Soc Radiol. 2021 Feb 16;105(1):9
pubmed: 33634237
Acad Emerg Med. 2020 Sep;27(9):811-820
pubmed: 32734624
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Euro Surveill. 2020 Nov;25(47):
pubmed: 33243355
Travel Med Infect Dis. 2020 Mar - Apr;34:101623
pubmed: 32179124
BMC Infect Dis. 2021 Jun 2;21(1):516
pubmed: 34078301
Intensive Care Med. 2020 Oct;46(10):1924-1926
pubmed: 32671470
Eur Radiol. 2021 Nov;31(11):8354-8363
pubmed: 33914118
J Med Internet Res. 2020 Oct 22;22(10):e20748
pubmed: 33006938
PLoS One. 2020 Aug 25;15(8):e0237302
pubmed: 32841294
Acad Emerg Med. 2020 Apr;27(4):309-311
pubmed: 32124506
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
AJR Am J Roentgenol. 2020 May;214(5):1072-1077
pubmed: 32125873
Ann Intern Med. 2020 May 05;172(9):577-582
pubmed: 32150748
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
Chest. 2020 Jul;158(1):106-116
pubmed: 32275978
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Chest. 2021 Oct;160(4):1222-1231
pubmed: 34004154
Cytokine Growth Factor Rev. 2020 Jun;53:38-42
pubmed: 32360420
Med Mal Infect. 2020 Jun;50(4):384
pubmed: 32240719
BMJ. 2020 Mar 26;368:m1091
pubmed: 32217556
Radiology. 2021 Feb;298(2):E63-E69
pubmed: 32729811
Radiology. 2020 Aug;296(2):E32-E40
pubmed: 32101510
Radiology. 2021 Jan;298(1):E30-E37
pubmed: 32776832
Chin Med J (Engl). 2020 Jun 5;133(11):1261-1267
pubmed: 32209890
JAMA. 2020 May 12;323(18):1843-1844
pubmed: 32159775
Ann Emerg Med. 2020 Oct;76(4):405-412
pubmed: 32563600
Chest. 2020 Jul;158(1):97-105
pubmed: 32304772
Nature. 2020 Mar 13;:
pubmed: 32203355
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1430-1434
pubmed: 32267160
Eur Respir J. 2020 May 7;55(5):
pubmed: 32269088

Auteurs

Anthony Chauvin (A)

Emergency Department and PreHospital EMS, Lariboisiere Hospital, Assistance Publique Hôpitaux de Paris, 75610 Paris, France.
Inserm U942 MASCOT, University of Paris, 75015 Paris, France.

Anna Slagman (A)

Departments of Emergency and Acute Medicine, Campus Mitte, Virchow-Klinikum Charité-Universitätsmedizin, 10117 Berlin, Germany.

Effie Polyzogopoulou (E)

Emergency Medicine Department, Attikon University Hospital, 12462 Athens, Greece.

Lars Petter Bjørnsen (LP)

Clinic of Emergency Medicine and Prehospital Care, Department of Circulation and Medical Imaging, St. Olav's University Hospital, Norwegian University of Science and Technology (NTNU), 7034 Trondheim, Norway.

Visnja Nesek Adam (VN)

Resuscitation and Intensive Care, University Department of Anesthesiology, Sveti Duh, University Hospital, 10000 Zagreb, Croatia.

Ari Palomäki (A)

Emergency Department, Division of Medicine, Kanta-Häme Central Hospital, 13530 Hämeenlinna, Finland.
Faculty of Medicine and Health Technology, Tampere University, 33100 Tampere, Finland.

Andrea Fabbri (A)

Emergency Department, Presidio Ospedaliero Morgagni-Pierantoni, AUSL Romagna, 47121 Forlì, Italy.

Said Laribi (S)

Emergency Medicine Department, Tours University Hospital, 37044 Tours, France.
School of Medicine, Tours University, 37000 Tours, France.

Classifications MeSH